TIPCO GROUP combines technology, expertise, and scientific insight to transform healthcare delivery. Our holistic approach is designed to improve clinical outcomes and optimize the experience for healthcare providers and patients alike.
The Centers for Medicare & Medicaid Services (CMS) has delayed the effective date of its Local Coverage Determinations (LCDs) for skin substitute grafts—impacting placental allografts—until January 1, 2026, citing a broader review to maintain patient access
In April 2025, CMS announced it is reviewing coverage policies for skin substitute products, delaying the effective date of the Skin Substitute Grafts/Cellular and Tissue-Based Products (CTPs) LCDs to January 1, 2026. For providers and patients using placental allografts (e.g., amnion/chorion), the decision preserves the status quo on Medicare coverage in the near term while the agency evaluates evidence standards and access implications. Policy stakeholders note that the delay gives wound-care clinics and manufacturers additional time to plan for reimbursement changes and documentation requirements likely to accompany any finalized LCDs.
Let's Build Healthier Solutions Together
Get in touch with our team to discuss your healthcare needs